Cerave Acne Clay-to-Foam Cleanser

Description

The product is identified by the SPL Code 34089-3. It is presented in a primary container with a volume of 118 mL. The associated media type for the product is image/jpeg, indicating that visual representation is available in this format.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne blemishes and facilitates the healing of the skin. Additionally, it helps prevent the formation of new acne blemishes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For use as a cleanser, the product should be applied twice daily. Healthcare professionals should instruct patients to massage the cleanser onto the skin using wet hands, allowing the clay to transform into foam. It is important to advise patients to avoid contact with the eyes; in the event of contact, they should rinse thoroughly with water. After application, the product must be rinsed well from the skin.

When used as a mask, an even layer of the product should be applied to clean, damp skin two times per week. Patients should be instructed to leave the mask on for ten minutes before rinsing it off thoroughly.

For spot treatment, the skin must be cleaned thoroughly prior to application. A thin layer of the product should be applied to the entire affected area one to three times daily. Due to the potential for excessive drying of the skin, it is recommended to start with one application daily, gradually increasing to two or three times daily as needed or as directed by a healthcare professional. If patients experience bothersome dryness or peeling, they should reduce the frequency of application to once a day or every other day.

Contraindications

Use of this product is contraindicated in patients who experience irritation. In such cases, it is advised to limit the use to one topical acne medication at a time to prevent exacerbation of irritation.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent unintended systemic exposure.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients should be instructed to contact a Poison Control Center or seek emergency medical help without delay.

Should irritation occur during treatment, it is crucial for patients to discontinue use and consult their healthcare provider. Additionally, it is recommended that patients utilize only one topical acne medication at a time to minimize the risk of adverse reactions and ensure optimal therapeutic outcomes.

Side Effects

For external use only. No specific side effects or adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Cerave Acne Clay-to-Foam Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of CeraVe Acne Clay-to-Foam Cleanser in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when recommending this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential sensitivities. Monitoring for any adverse reactions or skin sensitivities is advisable when this product is used in the geriatric population.

Pregnancy

Safety during pregnancy has not been established for this medication. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. Healthcare professionals should exercise caution when prescribing this medication to women of childbearing potential and consider alternative treatments that have a more established safety profile during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. It is important to monitor renal function tests regularly in patients with known kidney problems. In particular, a reduced dose should be considered for patients with a creatinine clearance of less than 30 mL/min.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management for suspected cases of drug overdosage.

Recommended Actions In the event of an overdosage, it is essential to assess the patient's clinical status promptly. Healthcare providers should initiate supportive care, which may include monitoring vital signs and providing symptomatic treatment as necessary.

Potential Symptoms While specific symptoms related to overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise following excessive intake of the medication.

Management Procedures Management of overdosage should be tailored to the individual patient and may involve the use of activated charcoal if the ingestion occurred within a suitable timeframe. In cases of severe toxicity, advanced medical interventions may be required. Consultation with a poison control center or a medical toxicologist is recommended for guidance on specific management strategies.

In summary, due to the lack of detailed overdosage information, healthcare professionals should rely on established protocols for managing suspected overdosage and remain alert to the potential for adverse effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication concurrently with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. This guidance will help ensure safe and effective use of the medication while reducing the potential for adverse skin reactions.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

For patients using the product, the recommended administration methods vary based on the intended use. As a cleanser, it should be applied twice daily. When used as a mask, an even layer should be applied to clean, damp skin two times per week. For spot treatment, a thin layer should cover the entire affected area one to three times daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cerave Acne Clay-to-Foam Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)